QUOIN PHARMAC.ADR 60000

Depository Receipt · US74907L3006 · QNRX · A3EJL7 (XNCM)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

31.10.2025 21:09

Current Prices from QUOIN PHARMAC.ADR 60000

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	QNRX	USD	31.10.2025 21:09	10,85 USD	-0,57 USD -4,99 %

Share Float & Liquidity

Free Float 609,07 %

Shares Float 3,58 M

Shares Outstanding 588.166,00

Company Profile for QUOIN PHARMAC.ADR 60000 Depository Receipt

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

Get up to date insights from finAgent about QUOIN PHARMAC.ADR 60000

Company Data

Name QUOIN PHARMAC.ADR 60000

Company Quoin Pharmaceuticals, Ltd.

Symbol QNRX

Website https://quoinpharma.com

Primary Exchange

Frankfurt

WKN A3EJL7

ISIN US74907L3006

Asset Class Depository Receipt

Sector Healthcare

Industry Biotechnology

CEO Michael Myers

Country United States of America

Currency EUR

Employees 0,0 T

Address 42127 Pleasant Forest Court, 20148-7349 Ashburn

IPO Date 2016-08-01

Stock Splits

Date	Split
09.04.2025	1:35
08.04.2025	1:20

ID Changes

Date	From	To
29.10.2021	APOP	QNRX

Ticker Symbols

Name	Symbol
NASDAQ	QNRX

More Shares

Investors who hold QUOIN PHARMAC.ADR 60000 also have the following shares in their portfolio:

PULMATRIX INC Share

X.2-EOZ.G.B0-1E 1CEOA ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog